Daily Archives: March 1, 2011

Science Speaks hosts a compelling series on medical male circumcision

By on .

Science Speaks hosted a series of Question & Answer-style interviews with major players in the effort to reduce HIV incidence via scaling up medical male circumcision (MC) in sub-Saharan Africa. The series includes compelling interviews with Dr. Caroline Ryan of the Office of the Global AIDS Coordinator, Jhpiego’s Kelly Curran, African journalist Kennedy Gondwe, and the MC program lead at the Tanzania Ministry of Health. Content highlights include how male circumcision outreach has spurred treatment demand in Kenya, plus a special update from the PEPFAR Swaziland team on the accelerated saturation innitiative starting up now.

Jhpiego’s Kelly Curran discusses efforts to scale up male circumcision

By on .

Kelly Curran (far right) stands in front of a sign for Tosamaganga Mission Hospital – which houses a Jhpiego-supported MC site – in Iringa, Tanzania. In this second post in a week-long series exploring efforts to reduce HIV incidence via scaling up medical male circumcision (MC) in sub-Saharan Africa, Meredith Mazzotta speaks with Kelly Curran, director […]

MSM and the HIV epidemic in low- and middle-income countries

By on .

Chris Beyrer, MD, MPH, from Johns Hopkins University offered an elegant overview of the epidemiology of the HIV epidemic among men who have sex with men (MSM) in low- and middle-income countries during a symposium at the 18th Conference on Retroviruses and Opportunistic Infections on Monday entitled “Responding to Risk”.  This meta-analysis looked at four […]

Cost-effectiveness in HIV care

By on .

Rochelle Walensky, MD, MPH, who has published widely on the cost effectiveness of HIV interventions domestically and globally, offered a plenary presentation on the subject at the 18th Conference on Retroviruses and Opportunistic Infections in Boston Tuesday morning. The World Health Organization (WHO) has developed criteria that calls a cost-per-year-of-life-saved that is less than or […]

Rectal-specific formulation of tenofovir gel shows promising results early on

By on .

Early-phase study reports looking at the use of a microbicidal tenofovir gel proven to reduce HIV infection during vaginal sex have shown promising results when used rectally. The study results were presented at the 18th Conference on Retroviruses and Opportunistic Infections in Boston Monday. A strong antiviral effect was achieved when the gel was used […]